Login / Signup

H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.

Peter J LearyEdward HessAnna E BarónKelley R BranchGaurav ChoudharyCatherine L HoughBradley A MaronDavid D RalphJohn J RyanRyan J TedfordNoel S WeissRoham T ZamanianTim Lahm
Published in: American journal of respiratory and critical care medicine (2019)
Keyphrases
  • pulmonary hypertension
  • pulmonary artery
  • cardiovascular events
  • quality improvement
  • pulmonary arterial hypertension
  • risk factors
  • cardiovascular disease
  • type diabetes
  • coronary artery disease